Fidelity Investments’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $288K | Buy |
201,358
+7,608
| +4% | +$10.9K | ﹤0.01% | 3176 |
|
|
2025
Q1 | $310K | Sell |
193,750
-24,615
| -11% | -$39.4K | ﹤0.01% | 3077 |
|
|
2024
Q4 | $786K | Buy |
218,365
+32,424
| +17% | +$117K | ﹤0.01% | 2757 |
|
|
2024
Q3 | $1.06M | Buy |
185,941
+162,314
| +687% | +$925K | ﹤0.01% | 2581 |
|
|
2024
Q2 | $109K | Sell |
23,627
-13,661
| -37% | -$63.1K | ﹤0.01% | 3260 |
|
|
2024
Q1 | $305K | Sell |
37,288
-272
| -0.7% | -$2.22K | ﹤0.01% | 2877 |
|
|
2023
Q4 | $212K | Sell |
37,560
-83,605
| -69% | -$472K | ﹤0.01% | 2945 |
|
|
2023
Q3 | $225K | Buy |
121,165
+66,398
| +121% | +$124K | ﹤0.01% | 2858 |
|
|
2023
Q2 | $151K | Sell |
54,767
-335
| -0.6% | -$921 | ﹤0.01% | 3027 |
|
|
2023
Q1 | $173K | Buy |
55,102
+2,763
| +5% | +$8.68K | ﹤0.01% | 3032 |
|
|
2022
Q4 | $309K | Sell |
52,339
-5,181
| -9% | -$30.6K | ﹤0.01% | 2873 |
|
|
2022
Q3 | $504K | Buy |
57,520
+56,210
| +4,291% | +$493K | ﹤0.01% | 2780 |
|
|
2022
Q2 | $10K | Sell |
1,310
-597,971
| -100% | -$4.56M | ﹤0.01% | 4104 |
|
|
2022
Q1 | $14.5M | Sell |
599,281
-49,700
| -8% | -$1.21M | ﹤0.01% | 1946 |
|
|
2021
Q4 | $20.9M | Hold |
648,981
| – | – | ﹤0.01% | 1804 |
|
|
2021
Q3 | $29M | Buy |
648,981
+69,700
| +12% | +$3.11M | ﹤0.01% | 1666 |
|
|
2021
Q2 | $21.9M | Buy |
579,281
+240,894
| +71% | +$9.12M | ﹤0.01% | 1817 |
|
|
2021
Q1 | $12.5M | Sell |
338,387
-332,900
| -50% | -$12.3M | ﹤0.01% | 1962 |
|
|
2020
Q4 | $22.2M | Buy |
+671,287
| New | +$22.2M | ﹤0.01% | 1674 |
|